<

Newbury Racecourse (NYR) continues to progress its development plans and some of the benefits are shown by the near-doubling of conference and events revenues in the first half. The remodelling of the main parade ring has been completed and a contractor appointed for work on the Royal Box, which will cost £2.5m. In the six months to June 2019, revenues were 3% higher at £7.57m, even though one race day was lost, and there was a slightly lower pre-exceptional loss of £317,000. There is a danger that legislation relating to fixed-odds betting terminals could have a knock-on effect on Newbury’s revenues from bookies in the second half.

Shepherd Neame (SHEP) will be releasing its annual results on Wednesday. Peel Hunt expects pre-tax profit to be 5% lower at £11.2m because there was no contribution from the Asahi brewing contract that ended in 2018. Excluding that contract, profit could have risen. Pubs have grown their like-for-like income and brewing volumes have recovered, but the second-half profit could be minimal. NAV of 1664p a share is forecast.

Healthcare IT provider DXS International (DXSP) has been hit by a short-term lack of sales activity in the NHS. In the year to April 2019, DXS reported an increased loss of £200,000, up from £46,000. Revenues dipped from £3.41m to £3.35m. More than £1m was spent on developing products during the year.

Ananda Developments (ANA) says that dry herb medical inhalation system Hapac has been refined and sales of the device and Hapac sachets are growing. However, legal uncertainty in Italy means that Hapac has been removed from sale while a court case over labelling and cannabis content is heard in Parma. There are plans to launch Hapac in other markets. Ananda has a 15% stake in Hapac’s owner. Edward Nealon has increased his stake in Ananda from 5.31% to 6.91%.

AfriAg Global (AFRI) says that Apollon Formularies, a Jamaican cannabis company where it owns 2.325% and it intends to acquire the rest of the shares, has completed a six-week pilot opening of a medicinal cannabis therapy centre to treat patients.

Karoo Energy (KEP) is in discussions with investors so that the company can be recapitalised and settle outstanding creditors. NEX Exchange has agreed to defer the withdrawal of Karoo shares from trading ahead of the publication of a circular.

AFH Financial (AFHP) has bought another IFA. It is paying up to £3.2m for Wirral-based Broadleaf Financial Services.

 

NEX Exchange Limited (”NEX Exchange”) accepts no responsibility for the content of this article or for any reliance placed by you or any person on the information contained therein.

By providing access to this material NEX Exchange does not intend to solicit business or offer any securities to any person in any country, whether directly or indirectly.

Articles available on nexexchange.com may be produced by independent third parties and are for distribution only under such circumstances as may be permitted by such third parties and applicable law. They are published solely for informational purposes and should not be construed as a recommendation to sell, buy or hold any product, investment, security or any other financial instrument. Any opinion, view or idea contained in any article is the author’s own and does not reflect or represent the opinions, views or ideas of NEX Exchange, nor any of its affiliates, directors, officers, employees or agents. Publication of the article does not signify endorsement by NEX Exchange of any of the information contained therein. NEX Exchange is not involved in the preparation of any such articles and does not make any representation or warranty, express or implied, as to the accuracy, completeness, suitability or correctness of any of the information presented by individual authors in the articles. In no circumstances will NEX Exchange, or any of its affiliates, directors, officers, employees or agents, be liable for any indirect or direct loss, or consequential loss or damages including without limitation, loss of business or profits arising from the use of, any inability to use, or any inaccuracy in the Information or views contained in the articlesAny opinions expressed in the articles are subject to change without notice and are not to be relied upon as investment advice, which should be sought from your independent advisers. NEX Exchange is under no obligation to update or keep current the information contained in the articles.

Please refer to the NEX Terms of Use for further information